Triferic
Total Payments
$307,353
Transactions
99
Doctors
31
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $5,208 | 4 | 2 |
| 2021 | $162,762 | 70 | 29 |
| 2018 | $21,050 | 4 | 2 |
| 2017 | $118,333 | 21 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $245,816 | 52 | 80.0% |
| Consulting Fee | $60,963 | 24 | 19.8% |
| Food and Beverage | $573.07 | 23 | 0.2% |
Payments by Type
Research
$245,816
52 transactions
General
$61,536
47 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Hemoglobin Maintenance in Pediatric ESRD Patients by Ferric Pyrophosphate Citrate (FPC) | Rockwell Medical, Inc. | $127,484 | 0 |
| Triferic Pediatric Pharmacokinetic Protocol | Rockwell Medical, Inc. | $61,321 | 0 |
| Equivalence of Triferic (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients | Rockwell Medical, Inc. | $53,233 | 0 |
| Pharmacokinetics and Preliminary Bioequivalence of Triferic (Ferric Pyrophosphate Citrate) Administered via Hemodialysate and Intravenously to Adult CKD-5HD Patients | Rockwell Medical, Inc. | $3,779 | 0 |
Top Doctors Receiving Payments for Triferic
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Cincinnati, OH | $245,816 | 52 |
| Gary Brittenham | — | New York, NY | $14,250 | 3 |
| , M.D | Internal Medicine | Webster, TX | $8,395 | 4 |
| Hartmut Malluche | — | Lexington, KY | $6,800 | 1 |
| , MD | Gastroenterology | Charlotte, NC | $6,000 | 1 |
| , MD | Nephrology | Chandler, AZ | $5,300 | 6 |
| , MD | Nephrology | Louisville, KY | $4,300 | 1 |
| , M.D | Nephrology | Salem, VA | $3,675 | 1 |
| , CRNP | Adult Health | Philadelphia, PA | $2,118 | 2 |
| , MD | Nephrology | Indianapolis, IN | $2,060 | 2 |
| , M.D | Specialist | Mineola, NY | $2,000 | 1 |
| , MD | Nephrology | Chapel Hill, NC | $2,000 | 1 |
| , MD | Nephrology | Springfield, MA | $2,000 | 1 |
| , M.D | Nephrology | Mountain View, CA | $2,000 | 1 |
| , M.D | Nephrology | Detroit, MI | $163.33 | 1 |
| , M.D | Medical Genetics, Ph.D. Medical Genetics | Christiansted, VI | $92.20 | 2 |
| , M.D | Nephrology | Rockville Centre, NY | $76.04 | 1 |
| , CNP | Adult Health | Zanesville, OH | $40.00 | 1 |
| , M.D | Nephrology | Manhattan, KS | $34.32 | 2 |
| , M.D | Nephrology | Lincoln, NE | $27.22 | 2 |
| , MD | Nephrology | Zanesville, OH | $26.67 | 1 |
| , MD | Internal Medicine | Indianapolis, IN | $25.52 | 2 |
| , ARNP | Nurse Practitioner | Davie, FL | $19.70 | 1 |
| , M.D | Internal Medicine | Philadelphia, PA | $18.70 | 1 |
| Steve Hernandez | Family | Corpus Christi, TX | $16.12 | 1 |
Ad
Manufacturing Companies
- Rockwell Medical, Inc. $307,353
Product Information
- Type Drug
- Total Payments $307,353
- Total Doctors 31
- Transactions 99
About Triferic
Triferic is a drug associated with $307,353 in payments to 31 healthcare providers, recorded across 99 transactions in the CMS Open Payments database. The primary manufacturer is Rockwell Medical, Inc..
Payment data is available from 2017 to 2022. In 2022, $5,208 was paid across 4 transactions to 2 doctors.
The most common payment nature for Triferic is "Unspecified" ($245,816, 80.0% of total).
Triferic is associated with 4 research studies, including "Hemoglobin Maintenance in Pediatric ESRD Patients by Ferric Pyrophosphate Citrate (FPC)" ($127,484).